Package 0006-3069-01

{"route": ["ORAL"], "spl_id": "20dc2455-4d48-4183-b1ad-29a2686dcd2a", "openfda": {"nui": ["N0000175463", "N0000009948", "N0000175460"], "upc": ["0300063069014"], "unii": ["913P6LK81M"], "rxcui": ["2055760", "2055766"], "spl_set_id": ["76ce1f00-28c0-4314-bd2c-d473fe3d0970"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0006-3069-01)", "package_ndc": "0006-3069-01", "marketing_start_date": "20180720"}], "brand_name": "PIFELTRO", "product_id": "0006-3069_20dc2455-4d48-4183-b1ad-29a2686dcd2a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "0006-3069", "generic_name": "doravirine", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PIFELTRO", "active_ingredients": [{"name": "DORAVIRINE", "strength": "100 mg/1"}], "application_number": "NDA210806", "marketing_category": "NDA", "marketing_start_date": "20180720", "listing_expiration_date": "20261231"}